Clinical Trial Update: SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors

View source ↗

Summary

A clinical trial exploring SARS-CoV-2 mRNA vaccination in patients with hepatocellular carcinoma undergoing treatment with immune checkpoint inhibitors; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Immune checkpoint inhibitors (immune checkpoint inhibitor)
• SARS-CoV-2 mRNA vaccine (mRNA vaccine against SARS-CoV-2)

Snippet

Sponsor: Medical University of Graz | Conditions: mRNA Vaccination, Hepatocellular Carcinoma | Status: NOT_YET_RECRUITING